Skip to main content

Table 2 Multivariate analysis of factors associated with alcohol abuse among HIV positive patients (n = 343)

From: Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes

Variable

n (%)

Crude PR (95CI)

p

Adjusted PR (95CI)

p

Genderc,f

 Female

27 (16.0)

1

0.001

1

0.001

 Male

71 (40.8)

2.55 (1.73–3.77)

2.88 (1.96–4.24)

Agec,f

 18–34

27 (27.3)

1

0.5b

1

0.08a

 35–54

59 (30.7)

1.13 (0.76–1.66)

0.81 (0.56–1.16)

 55 or older

12 (23.1)

0.85 (0.47–1.53)

0.61 (0.34–1.10)

Skin colorc,f

 White

60 (25.2)

1

0.01a

1

0.04a

 Mixed

17 (30.9)

1.23 (0.80–1.93)

1.10 (0.74–1.65)

 Black

21 (42.0)

1.67 (1.12–2.47)

1.44 (0.98–2.13)

Educationc,f

 Each year

 

0.93 (0.89–0.98)

0.005

0.95 (0.90–0.99)

0.03

Income (quartiles)c,f

 1st

22 (23.7)

1

0.006b

1

0.003b

 2nd

33 (40.2)

1.70 (1.08–2.67)

1.67 (1.08–2.60)

 3rd

29 (34.1)

1.44 (0.90–2.31)

1.18 (0.75–1.88)

 4th

14 (16.9)

0.71 (0.39–1.30)

0.67 (0.37–1.21)

Married/Cohabitingc

 No

53 (30.8)

1

0.3

1

0.7

 Yes

45 (26.3)

0.85 (0.61–1.20)

0.94 (0.69–1.29)

STDd

 No

80 (26.6)

1

0.02

1

0.5

 Yes

18 (42.9)

1.61 (1.08–2.40)

1.15 (0.79–1.68)

Number sexual partnersd

 Up to 2

76 (26.4)

1

0.03

1

0.2

 3 or more

22 (40.0)

1.52 (1.04–2.21)

1.25 (0.90–1.74)

Use of intravenous drugsd,f

 No

70 (23.6)

1

0.001

1

0.03

 Yes

28 (60.9)

2.58 (1.89–3.52)

1.45 (1.04–2.02)

Use of inhaled illicit drugsd,f

 No

43 (18.5)

1

0.001

1

0.001

 Yes

55 (49.5)

2.67 (1.92–3.71)

1.85 (1.28–2.68)

Previous hepatitisd

 No

71 (25.8)

1

0.02

1

0.5

 Yes

27 (39.7)

1.54 (1.08–2.19)

1.14 (0.80–1.60)

Length of HIV infectione

 Each year

 

0.997 (0.965–1.031)

0.9

0.989 (0.957–1.021)

0.5

Use of HAARTe

 No

7 (18.9)

1

0.2

1

0.2

 Yes

91 (29.7)

1.57 (0.79–3.13)

1.69 (0.81–3.54)

  1. aLinear trend test; bHeterogeneity test; c1st level; d2nd level; e3rd level; ffinal model